These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30901535)

  • 21. Genetics of Coronary Artery Disease.
    McPherson R; Tybjaerg-Hansen A
    Circ Res; 2016 Feb; 118(4):564-78. PubMed ID: 26892958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of the Emerging Genomics Data on the Management of Agerelated Phenotypes in the Context of Cellular Senescence.
    Montesanto A; Geracitano S; Garasto S; Fusco S; Lattanzio F; Passarino G; Corsonello A
    Curr Drug Targets; 2016; 17(4):428-38. PubMed ID: 25601329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capitalizing on Insights from Human Genetics to Identify Novel Therapeutic Targets for Coronary Artery Disease.
    Young EP; Stitziel NO
    Annu Rev Med; 2019 Jan; 70():19-32. PubMed ID: 30355262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene scanning and heart attack risk.
    Barth AS; Tomaselli GF
    Trends Cardiovasc Med; 2016 Apr; 26(3):260-5. PubMed ID: 26277204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide association studies in atherosclerosis.
    Sivapalaratnam S; Motazacker MM; Maiwald S; Hovingh GK; Kastelein JJ; Levi M; Trip MD; Dallinga-Thie GM
    Curr Atheroscler Rep; 2011 Jun; 13(3):225-32. PubMed ID: 21369780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The performance of a new local false discovery rate method on tests of association between coronary artery disease (CAD) and genome-wide genetic variants.
    Mei S; Karimnezhad A; Forest M; Bickel DR; Greenwood CMT
    PLoS One; 2017; 12(9):e0185174. PubMed ID: 28931044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide association studies of late-onset cardiovascular disease.
    Smith JG; Newton-Cheh C
    J Mol Cell Cardiol; 2015 Jun; 83():131-41. PubMed ID: 25870159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Genetic Basis of Metabolic Disease.
    Barroso I; McCarthy MI
    Cell; 2019 Mar; 177(1):146-161. PubMed ID: 30901536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of genome-wide association studies on the pathophysiology and therapy of cardiovascular disease.
    Kessler T; Vilne B; Schunkert H
    EMBO Mol Med; 2016 Jul; 8(7):688-701. PubMed ID: 27189168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying genes for coronary artery disease: An idea whose time has come.
    Roberts R; Stewart AF; Wells GA; Williams KA; Kavaslar N; McPherson R
    Can J Cardiol; 2007 Aug; 23 Suppl A(Suppl A):7A-15A. PubMed ID: 17668082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shared genetic aetiology of coronary artery disease and atherosclerotic stroke - 2015.
    Kessler T; Erdmann J; Dichgans M; Schunkert H
    Curr Atheroscler Rep; 2015 Apr; 17(4):498. PubMed ID: 25690589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic variants primarily associated with type 2 diabetes are related to coronary artery disease risk.
    Jansen H; Loley C; Lieb W; Pencina MJ; Nelson CP; Kathiresan S; Peloso GM; Voight BF; Reilly MP; Assimes TL; Boerwinkle E; Hengstenberg C; Laaksonen R; McPherson R; Roberts R; Thorsteinsdottir U; Peters A; Gieger C; Rawal R; Thompson JR; König IR; ; Vasan RS; Erdmann J; Samani NJ; Schunkert H
    Atherosclerosis; 2015 Aug; 241(2):419-26. PubMed ID: 26074316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adding Protective Genetic Variants to Clinical Reporting of Genomic Screening Results: Restoring Balance.
    Schwartz MLB; Williams MS; Murray MF
    JAMA; 2017 Apr; 317(15):1527-1528. PubMed ID: 28288260
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic determinants of response to statins.
    Peters BJ; Klungel OH; de Boer A; Maitland-van der Zee AH
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):977-83. PubMed ID: 19673675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential Impact of MicroRNA-423 Gene Variability in Coronary Artery Disease.
    Jha CK; Mir R; Elfaki I; Khullar N; Rehman S; Javid J; Banu S; Chahal SMS
    Endocr Metab Immune Disord Drug Targets; 2019; 19(1):67-74. PubMed ID: 30289085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association of polymorphic variants, rs2267788, rs1333049 and rs2383207 with coronary artery disease, its severity and presentation in North Indian population.
    Kashyap S; Kumar S; Agarwal V; Misra DP; Rai MK; Kapoor A
    Gene; 2018 Mar; 648():89-96. PubMed ID: 29309886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GWAS implicated risk variants in different genes contribute additively to increase the risk of coronary artery disease (CAD) in the Pakistani subjects.
    Shahid SU; Shabana NA; Rehman A; Humphries S
    Lipids Health Dis; 2018 Apr; 17(1):89. PubMed ID: 29673405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atherosclerosis: the path from genomics to therapeutics.
    Miller DT; Ridker PM; Libby P; Kwiatkowski DJ
    J Am Coll Cardiol; 2007 Apr; 49(15):1589-1599. PubMed ID: 17433948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transplant genetics and genomics.
    Yang JY; Sarwal MM
    Nat Rev Genet; 2017 May; 18(5):309-326. PubMed ID: 28286337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular genetics of coronary artery diseases].
    Ozaki K; Tanaka T
    Nihon Rinsho; 2016 Jun; 74 Suppl 4 Pt 1():306-13. PubMed ID: 27534188
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.